Aberrant, persistent inclusion into lipid rafts limits the tumorigenic function of membrane type-1 matrix metalloproteinase in malignant cells
- 18 November 2003
- journal article
- research article
- Published by Elsevier in Experimental Cell Research
- Vol. 293 (1) , 81-95
- https://doi.org/10.1016/j.yexcr.2003.10.006
Abstract
No abstract availableKeywords
This publication has 62 references indexed in Scilit:
- Prinomastat, a hydroxamate inhibitor of matrix metalloproteinases, has a complex effect on migration of breast carcinoma cellsInternational Journal of Cancer, 2003
- Role of pericellular proteolysis by membrane-type 1 matrix metalloproteinase in cancer invasion and angiogenesisCancer and Metastasis Reviews, 2003
- Regulation of membrane type-matrix metalloproteinasesSeminars in Cancer Biology, 2002
- New functions for the matrix metalloproteinases in cancer progressionNature Reviews Cancer, 2002
- Matrix Metalloproteinases (MMPs) Regulate Fibrin-invasive Activity via MT1-MMP–dependent and –independent ProcessesThe Journal of Experimental Medicine, 2002
- Matrix metalloproteinases: they're not just for matrix anymore!Current Opinion in Cell Biology, 2001
- Regulation of Cell Invasion and Morphogenesis in a Three-Dimensional Type I Collagen Matrix by Membrane-Type Matrix Metalloproteinases 1, 2, and 3The Journal of cell biology, 2000
- Matrix MetalloproteinasesJournal of Biological Chemistry, 1999
- Matrix metalloproteinases: structures, evolution, and diversificationThe FASEB Journal, 1998
- A matrix metalloproteinase expressed on the surface of invasive tumour cellsNature, 1994